Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF APRIL 17, 2026 SAM #8908
SOLICITATION NOTICE

R -- Plan Program Integrity Medicare Drug Integrity Contractor (PPI MEDIC)

Notice Date

4/15/2026 11:52:46 AM
 

Notice Type

Solicitation
 

NAICS

541990 — All Other Professional, Scientific, and Technical Services
 

Contracting Office

OFC OF ACQUISITION AND GRANTS MGMT BALTIMORE MD 21244 USA
 

ZIP Code

21244
 

Solicitation Number

260656J
 

Response Due

4/22/2026 7:00:00 AM
 

Archive Date

06/30/2026
 

Point of Contact

Jennifer Kuhn, Phone: 4107862299, Kyle Patton, Phone: 4107868714
 

E-Mail Address

jennifer.kuhn@cms.hhs.gov, kyle.patton@cms.hhs.gov
(jennifer.kuhn@cms.hhs.gov, kyle.patton@cms.hhs.gov)
 

Small Business Set-Aside

WOSB Women-Owned Small Business
 

Description

***Amendment 1 *** 75FCMC26R0041, Plan Program Integrity Medicare Drug Integrity Contractor (PPI MEDIC), is hereby amended as follows. All changes are identified in RED throughout the referenced documents: Exhibit E.1 � Solicitation Section L&M � Amendment 1: Page numbers have been added. Section L.2(b) � has been updated to extend the �Notice of Intent� submission date to April 17, 2026, by 10:00:00 AM, local time, Baltimore, MD. Section L.3 � has been updated to extend the Phase 1 proposal received date to no later than April 22, 2026, 10:00:00 AM local time, Baltimore, MD. Section L.4(a) � has been updated to provide clarification that Volume III and IV are part of the Phase 2 submission. Section L.6 � the section title has been updated to provide clarification that Volume III is part of the Phase 2 submission. Section L.6(a) � has been updated to correct the business proposal volume reference from II to III. Section L.6(a)(5) � has been updated to clarify that the accounting system determination will be made at the time of the Phase 2 proposal submission. Section L.6(a)(10) � has been updated to remove reference to �Teaming Arrangements�. Section L.7 - the section title has been updated to provide clarification that Volume IV is part of the Phase 2 submission. Section M.2 � has been updated to clarify eligibility requirements. Section M.5 � has been updated to clarify that evaluations for Phase 1 and Phase 2 will be utilized in the �tradeoff� analysis to determine which proposal offers the best combination of technical capabilities and price to the Government. Section J: Exhibit E.2 � PPI MEDIC Questions Submission Template has been replaced with Exhibit E.2 PPI MEDIC Questions Response - Amendment 1 and includes answers to questions that CMS determined to be necessary for proposal preparation. Exhibit E.8 � Business Proposal Template - Amendment 1- has been updated to removed text from row 152 that was unintentionally included in the template. Exhibit E.8 � Business Proposal Template - Amendment 1- has been updated to provide clarification to Offeror�s that they should incorporate the costs associated with Task 1 in Attachment J.1 - PPI MEDIC - Statement of Work under Task 6 - Administrative Requirements. Attachment J.1 � PPI MEDIC � Statement of Work � Amendment 1 � Section 2.6 � Audits � has been updated to provide clarification on Remedy Action Plans (RAPs) and Corrective Action Plans (CAPs). Attachment J.1 � PPI MEDIC � Statement of Work � Amendment 1 � Section 2.6.2 � Program Integrity (PI) Audits � has been updated to include ""and/or"", to ensure flexibility in audit location (i.e. virtual or onsite). Attachment J.1 � PPI MEDIC � Statement of Work � Amendment 1 � Section 3.1 � Incoming Transition Requirements� has been updated to include additional transition clarifications. Attachment J.1 � PPI MEDIC � Statement of Work � Amendment 1 � Section 3.2 � Outgoing Transition Requirements� has been updated to include additional transition clarifications. Attachment J.1 � PPI MEDIC � Statement of Work � Amendment 1 � Appendix A- Deliverables Schedule� has been updated to include additional transition-out deliverables associated with SOW Section 3.2. Attachment J.1 � PPI MEDIC � Statement of Work � Amendment 1 � Appendix A- Deliverables Schedule� has been updated to renumber deliverables 19-32. *** Original *** The PPI MEDIC serves as a national contractor responsible for providing oversight of the Medicare Parts C and D programs to ensure the protection of the Medicare Trust Fund. CMS seeks to contract with an external entity to support CMS audits and program integrity oversight activities related to fraud, waste, and abuse efforts within the Medicare Parts C and D programs. Its tasks include data analysis, audits and reviews of Medicare Advantage Organizations (MAOs), including Medicare Advantage Prescription Drug (MA-PD) plan sponsors and Prescription Drug Plan (PDP) sponsors, as well as outreach, education, and referrals to law enforcement.
 

Web Link

SAM.gov Permalink
(https://sam.gov/workspace/contract/opp/5d27b49b99d94859af6691e8e6a5b17f/view)
 

Place of Performance

Address: 0, MD 21244, USA

Zip Code: 21244

Country: USA
 

Record

SN07780115-F 20260417/260415230043 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |